Abstract
As we age, there is an increased risk for the development of pulmonary diseases, including infections, but few studies have considered changes in lung surfactant and components of the innate immune system as contributing factors to the increased susceptibility of the elderly to succumb to infections. We and others have demonstrated that human alveolar lining fluid (ALF) components, such as surfactant protein (SP)-A, SP-D, complement protein C3, and alveolar hydrolases, play a significant innate immune role in controlling microbial infections. However, there is a lack of information regarding the effect of increasing age on the level and function of ALF components in the lung. Here we addressed this gap in knowledge by determining the levels of ALF components in the aging lung that are important in controlling infection. Our findings demonstrate that pro-inflammatory cytokines, surfactant proteins and lipids, and complement components are significantly altered in the aged lung in both mice and humans. Further, we show that the aging lung is a relatively oxidized environment. Our study provides new information on how the pulmonary environment in old age can potentially modify mucosal immune responses, thereby impacting pulmonary infections and other pulmonary diseases in the elderly population.
Similar content being viewed by others
References
Arcos J, Sasindran SJ, Fujiwara N, Turner J, Schlesinger LS, Torrelles JB (2011) Human lung hydrolases delineate Mycobacterium tuberculosis-macrophage interactions and the capacity to control infection. J Immunol 187:372–381
Baylis D, Bartlett D, Patel H, Roberts H (2013) Understanding how we age: insights into inflammaging. Longev Healthspan 2:1–8
Beharka AA, Gaynor CD, Kang BK, Voelker DR, McCormack FX, Schlesinger LS (2002) Pulmonary surfactant protein A up-regulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophages. J Immunol 169:3565–3573
Betsuyaku T, Nishimura M, Takeyabu K, Tanino M, Venge P, Xu S et al (1999) Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Am J Respir Crit Care Med 159:1985–1991
Betsuyaku T, Kuroki Y, Nagai K, Nasuhara Y, Nishimura M (2004) Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid. Eur Respir J 24:964–970
Bolger MS, Ross DS, Jiang H, Frank MM, Ghio AJ, Schwartz DA et al (2007) Complement levels and activity in the normal and LPS-injured lung. Am J Physiol Lung Cell Mol Physiol 292:L748–L759
Bridges JP, Davis HW, Damodarasamy M, Kuroki Y, Howles G, Hui DY et al (2000) Pulmonary surfactant proteins A and D are potent endogenous inhibitors of lipid peroxidation and oxidative cellular injury. J Biol Chem 275:38848–38855
Burton DGA (2009) Cellular senescence, ageing and disease. Age (Dordr) 31:1–9
Busse PJ, Mathur SK (2010) Age-related changes in immune function: effect on airway inflammation. J Allergy Clin Immunol 126:690–699
Carlson TK, Brooks M, Meyer D, Henning L, Murugesan V et al (2010) Pulmonary innnate immunity: soluble and cellular host defenses of the lung. In: Marsh C, Tridandapani S, Piper M (eds) Regulation of innate immune function. Transworld Research Network, Kerala, pp 165–211
Clay CD, Soni S, Gunn JS, Schlesinger LS (2008) Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen. J Immunol 181:5568–5578
Cole FS, Matthews WJ Jr, Rossing TH, Gash DJ, Lichtenberg NA, Pennington JE (1983) Complement biosynthesis by human bronchoalveolar macrophages. Clin Immunol Immunopathol 27:153–159
Crowther JE, Kutala VK, Kuppusamy P, Ferguson JS, Beharka AA, Zweier JL et al (2004) Pulmonary surfactant protein a inhibits macrophage reactive oxygen intermediate production in response to stimuli by reducing NADPH oxidase activity. J Immunol 172:6866–6874
Cruz-Hervert LP, Garcia-Garcia L, Ferreyra-Reyes L, Bobadilla-del-Valle M, Cano-Arellano B, Canizales-Quintero S et al (2012) Tuberculosis in ageing: high rates, complex diagnosis and poor clinical outcomes. Age Ageing 41:488–495
Dalle-Donne I, Scaloni A, Giustarini D, Cavarra E, Tell G, Lungarella G et al (2005) Proteins as biomarkers of oxidative/nitrosative stress in diseases: the contribution of redox proteomics. Mass Spectrom Rev 24:55–99
de Vries AC, Schram AW, Tager JM, Batenburg JJ, van Golde LM (1985) A specific acid alpha-glucosidase in lamellar bodies of the human lung. Biochim Biophys Acta 837:230–238
DiAugustine RP (1974) Lung concentric laminar organelle. Hydrolase activity and compositional analysis. J Biol Chem 249:584–593
Doria G, D’Agostaro G, Poretti A (1978) Age-dependent variations of antibody avidity. Immunology 35:601–611
Dyer C (2012) The interaction of ageing and lung disease. Chron Respir Dis 9:63–67
Eaton SM, Burns EM, Kusser K, Randall TD, Haynes L (2004) Age-related defects in CD4 T cell cognate helper function lead to reductions in humoral responses. J Exp Med 200:1613–1622
Edelson JD, Shannon JM, Mason RJ (1988) Alkaline phosphatase: a marker of alveolar type II cell differentiation. Am Rev Respir Dis 138:1268–1275
Ferguson JS, Voelker DR, McCormack FX, Schlesinger LS (1999) Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages. J Immunol 163:312–321
Ferguson JS, Weis JJ, Martin JL, Schlesinger LS (2004) Complement protein C3 binding to Mycobacterium tuberculosis is initiated by the classical pathway in human bronchoalveolar lavage fluid. Infect Immun 72:2564–2573
Ferguson JS, Martin JL, Azad AK, McCarthy TR, Kang PB, Voelker DR et al (2006) Surfactant protein D increases fusion of Mycobacterium tuberculosis-containing phagosomes with lysosomes in human macrophages. Infect Immun 74:7005–7009
Figueroa JE, Densen P (1991) Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 4:359–395
Fragoso CAV, Lee PJ (2012) The aging lung. J Gerontol 67A:233–235
Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E et al (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908:244–254
Gaynor CD, McCormack FX, Voelker DR, McGowan SE, Schlesinger LS (1995) Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. J Immunol 155:5343–5351
Geunes-Boyer S, Oliver TN, Janbon G, Lodge JK, Heitman J, Perfect JR et al (2009) Surfactant protein D increases phagocytosis of hypocapsular Cryptococcus neoformans by murine macrophages and enhances fungal survival. Infect Immun 77:2783–2794
Gilder H, Haschemeyer RH, Fairclough GF Jr, Mynarcik DC (1981) Isolation and characterization of lamellar body material from rat lung homogenates by continuous linear sucrose gradients. J Lipid Res 22:1277–1285
Gupta GS, Gupta A, Gupta RK (2012) Animal lectins: form, functions and clinical applications. Springer, London
Hawgood S, Poulain FR (2001) The pulmonary collectins and surfactant metabolism. Annu Rev Physiol 63:495–519
Hayakawa H, Giridhar G, Myrvik QN, Kucera L (1992) Pulmonary surfactant phospholipids modulate priming of rabbit alveolar macrophages for oxidative responses. J Leukoc Biol 51:379
Henning LN, Azad AK, Parsa KV, Crowther JE, Tridandapani S, Schlesinger LS (2008) Pulmonary surfactant protein A regulates TLR expression and activity in human macrophages. J Immunol 180:7847–7858
Ho E, Karimi GK, Liu CC, Bhindi R, Figtree GA (2013) Biological markers of oxidative stress: applications to cardiovascular research and practice. Redox Biol 1:483–491
Hook GE (1978) Extracellular hydrolases of the lung. Biochemistry 17:520–528
Hook GE, Gilmore LB (1982) Hydrolases of pulmonary lysosomes and lamellar bodies. J Biol Chem 257:9211–9220
Ito K, Barnes PJ (2009) COPD as a disease of accelerated lung aging. Chest 135:173–180
Kang PB, Azad AK, Torrelles JB, Kaufman TM, Beharka A, Tibesar E et al (2005) The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J Exp Med 202:987–999
King RJ (1982) Pulmonary surfactant. J Appl Physiol 53:1–8
Laskin DL, Pendino KJ (1995) Macrophages and inflammatory mediators in tissue injury. Annu Rev Pharmacol Toxicol 35:655–677
Lusuardi M, Capelli A, Carli S, Tacconi MT, Salmona M, Donner CF (1992) Role of surfactant in chronic obstructive pulmonary disease: therapeutic implications. Respiration 59(Suppl 1):28–32
Mason RJ (2006) Biology of alveolar type II cells. Respirology 11(Suppl):S12–S15
Mauderly JL, Hahn FF (1982) The effects of age on lung function and structure of adult animals. Adv Vet Sci Comp Med 26:35–77
Meyer KC, Ershler W, Rosenthal NS, Lu XG, Peterson K (1996) Immune dysregulation in the aging human lung. Am J Respir Crit Care Med 153:1072–1079
Mold C (1999) Role of complement in host defense against bacterial infection. Microbes Infect 1:633–638
Nguyen HA, Rajaram MV, Meyer DA, Schlesinger LS (2012) Pulmonary surfactant protein A and surfactant lipids upregulate IRAK-M, a negative regulator of TLR-mediated inflammation in human macrophages. Am J Physiol Lung Cell Mol Physiol 303:L608–L616
Notter RH (2000) Lung surfactants: basic science and clinical applications. Marcel Dekker, New York, pp 1–444
Notter RH, Tabak SA, Mavis RD (1980) Surface properties of binary mixtures of some pulmonary surfactant components. J Lipid Res 21:10–22
Olson DR, Heffernan RT, Paladini M, Konty K, Weiss D, Mostashari F (2007) Monitoring the impact of influenza by age: emergency department fever and respiratory complaint surveillance in New York City. PLoS Med 4:e247
Postle AD (2008) Phospholipid profiling. In: Griffiths W (ed) Metabolomics, metabonomics, and metabolite profiling. The Royal Society of Chemistry, Cambridge, pp 116–133
Rebello CM, Jobe AH, Eisele JW, Ikegami M (1996) Alveolar and tissue surfactant pool sizes in humans. Am J Respir Crit Care Med 154:625–628
Reid KB, Clark H, Palaniyar N (2005) Surfactant and lung inflammation. Thorax 60:620–622
Retini C, Kozel TR, Pietrella D, Monari C, Bistoni F, Vecchiarelli A (2001) Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans. Infect Immun 69:6064–6073
Reynolds HY (1987) Lung inflammation: normal host defense or a complication of some diseases? Annu Rev Med 38:295–323
Robertson J, Caldwell JR, Castle JR, Waldman RH (1976) Evidence for the presence of components of the alternative (properdin) pathway of complement activation in respiratory secretions. J Immunol 117:900–903
Romano AD, Serviddio G, de Matthaeis A, Bellanti F, Vendemiale G (2010) Oxidative stress and aging. J Nephrol 23(Suppl 15):S29–S36
Saraiva M, O’Garra A (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10:170–181
Schlesinger LS, Bellinger-Kawahara CG, Payne NR, Horwitz MA (1990) Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J Immunol 144:2771–2780
Schunemann HJ, Muti P, Freudenheim JL, Armstrong D, Browne R, Klocke RA et al (1997) Oxidative stress and lung function. Am J Epidemiol 146:939–948
Strunk RC, Eidlen DM, Mason RJ (1988) Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways. J Clin Invest 81:1419–1426
Taffet GE, Donohue JF, Altman PR (2014) Considerations for managing chronic obstructive pulmonary disease in the elderly. Clin Interv Aging 9:23–30
Tedesco F (2008) Inherited complement deficiencies and bacterial infections. Vaccine 26(Suppl 8):I3–I8
Tonks A, Morris RH, Price AJ, Thomas AW, Jones KP, Jackson SK (2001) Dipalmitoylphosphatidylcholine modulates inflammatory functions of monocytic cells independently of mitogen activated protein kinases. Clin Exp Immunol 124:86–94
Torrelles JB (2012) Broadening our view about the role of Mycobacterium tuberculosis cell envelope components during infection: a battle for survival. In: Cardona PJ (ed) Understanding tuberculosis—analyzing the origin of Mycobacterium tuberculosis pathogenicity. Intech, Rijeka, pp 1–46
Umstead TM, Freeman WM, Chinchilli VM, Phelps DS (2009) Age-related changes in the expression and oxidation of bronchoalveolar lavage proteins in the rat. Am J Physiol Lung Cell Mol Physiol 296:L14–L29
van Golde LM (1985) Synthesis of surfactant lipids in the adult lung. Annu Rev Physiol 47:765–774
Veldhuizen R, Nag K, Orgeig S, Possmayer F (1998) The role of lipids in pulmonary surfactant. Biochim Biophys Acta 1408:90–108
Walti H, Polla BS, Bachelet M (1997) Modified natural porcine surfactant inhibits superoxide anions and proinflammatory mediators released by resting and stimulated human monocytes. Pediatr Res 41:114–119
Wang SH, Carruthers B, Turner J (2012) The influence of increasing age on susceptibility of the elderly to tuberculosis. Open Longetivity Science 6:73–82
Watford WT, Wright JR, Hester CG, Jiang H, Frank MM (2001) Surfactant protein A regulates complement activation. J Immunol 167:6593–6600
Williams MC (2003) Alveolar type I cells: molecular phenotype and development. Annu Rev Physiol 65:669–695
Wroe PC, Finkelstein JA, Ray GT, Linder JA, Johnson KM, Rifas-Shiman S et al (2012) Aging population and future burden of pneumococcal pneumonia in the United States. J Infect Dis 205:1589–1592
Young SL, Fram EK, Larson E, Wright JR (1993) Recycling of surfactant lipid and apoprotein-A studied by electron microscopic autoradiography. Am J Physiol Lung Cell Mol Physiol 265:L19–L26
Yu SH, Possmayer F (1996) Effect of pulmonary surfactant protein A and neutral lipid on accretion and organization of dipalmitoylphosphatidylcholine in surface films. J Lipid Res 37:1278–1288
Acknowledgements
This work was supported by a The Ohio State University Public Health Preparedness for Infectious Diseases (PHPID) pilot award to JT, JBT, LSS, WL, SW, J(X)P, and PR Jr, and a Julie Martin Mid-Career American Federation of Aging Research (AFAR) award to JT, and partially by a NIH/NIAD R01 [AI-093570] to JBT. JIM was partially supported by a NIH/NIGMS T32-GM068412. We thank Dr. Patsy Skabla for assisting with patient enrollment. We also thank the Campus Chemical Instrument Center (CCIC) at The Ohio State University for their services.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Juan I. Moliva and Murugesan V. S. Rajaram contributed equally to this work.
About this article
Cite this article
Moliva, J.I., Rajaram, M.V.S., Sidiki, S. et al. Molecular composition of the alveolar lining fluid in the aging lung. AGE 36, 1187–1199 (2014). https://doi.org/10.1007/s11357-014-9633-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11357-014-9633-4